SALT LAKE CITY – ARUP Laboratories invites medical professionals and others to participate in a free webinar that features lab industry leaders discussing how COVID-19-related societal and behavioral changes may permanently affect the laboratory industry.
ARUP Laboratories and technology company Techcyte published a study in the Journal of Clinical Microbiology on their AI-augmented ova-and-parasite detection tool.
ARUP and the Utah Department of Health Study the Genetics of COVID-19 to Understand How the Virus Has Spread in Utah
David Hillyard, MD, (left) medical director of ARUP’s Molecular Infectious Diseases Laboratory, and Kelly Oakeson, PhD, (right) Utah Public Health Laboratory chief scientist of bioinformatics and next generation sequencing, are studying the genetics of the COVID-19 virus in Utah.
A Whole New Microscopic World: ARUP/Techcyte Publish First Peer-Reviewed Study on AI-based Protozoa Detection
SALT LAKE CITY— ARUP Laboratories, a national reference laboratory and worldwide leader in innovative laboratory research and development, and Techcyte, a leading developer of artificial intelligence (AI)-based image analysis solutions for the diagnostics industry, published a study in the Journal of Clinical Microbiology on their groundbreaking AI-augmented ova
Utahns tested for COVID-19 at the University of Utah Redwood Health Center are being asked to volunteer for a study to evaluate whether saliva and other specimen types can be effectively used to test for the disease. The study is a collaboration between ARUP Laboratories and U of U Health.
SALT LAKE CITY—ARUP Laboratories today announced that it is making a second COVID-19 IgG antibody test available nationwide.
Sara Halford, an employee in ARUP’s Clinical Trials group, receives specimens for testing as part of a University of Utah study to evaluate the efficacy of hydroxychloroquine in the treatment of COVID-19.
ARUP to Provide Testing for a CDC-Funded Project to Reduce COVID-19 Risk in Hospital Emergency Departments
Patricia Slev, PhD, section chief of ARUP’s Immunology Division, (center) will serve as ARUP’s primary collaborator with researchers at the University of California, Los Angeles and the University of Iowa whose CDC-funded project seeks to reduce emergency department employees’ risk of contracting COVID-19.
Employees in ARUP’s Automated Core Lab will perform COVID-19 IgG antibody tests for participants in the Utah HERO project.
With Antibody Testing Now Available, ARUP Provides Testing Nationwide to Help Diagnose, Monitor, and Treat COVID-19
David Hillyard, MD, medical director of ARUP’s Molecular Infectious Diseases Lab, explains instrumentation used for COVID-19 molecular diagnostic tests to (from right to left) ARUP President Andy Theurer, Utah Gov. Gary Herbert, Utah Public Safety Commissioner Jess Anderson, Maj. Gen.
SALT LAKE CITY—ARUP Laboratories today announced it will begin rolling out COVID-19 antibody testing nationwide by the end of this week.
SALT LAKE CITY – As the state of Utah continues to expand testing to halt the spread of COVID-19, its two largest laboratory services providers are reaffirming their commitment to work together to meet all of the state’s COVID-19 testing needs.